17 Baillie Gifford Recursion Pharmaceuticals Trades
Baillie Gifford's position in Recursion Pharmaceuticals is currently worth $109M. That's 0.08% of their equity portfolio (121st largest holding). The investor owns 5.44% of the outstanding Recursion Pharmaceuticals stock. The first Recursion Pharmaceuticals trade was made in Q2 2021. Since then Baillie Gifford bought shares five more times and sold shares on eleven occasions. The investor's estimated purchase price is $605M, resulting in a loss of 82%.
Avg closing price
Price range
Sold 0.9% shares (-219k shares)
Q2 2025
Avg closing price
$4.91
Price range
$3.97
-
$5.84
Sold 1.9% shares (-471k shares)
Q1 2025
Avg closing price
$7.33
Price range
$5.29
-
$10.87
Sold 1.5% shares (-376k shares)
Q4 2024
Avg closing price
$6.72
Price range
$5.70
-
$8.27
Sold 5.1% shares (-1.35M shares)
Q3 2024
Avg closing price
$7.17
Price range
$5.92
-
$8.60
Increased shares by 10.5% (+2.52M shares)
Q2 2024
Avg closing price
$8.72
Price range
$7.35
-
$10.05
Sold 0.5% shares (-112k shares)
Q1 2024
Avg closing price
$11.14
Price range
$9.13
-
$15.52
Sold 1.5% shares (-372k shares)
Q4 2023
Avg closing price
$7.13
Price range
$5.09
-
$10.79
Sold 2.2% shares (-546k shares)
Q3 2023
Avg closing price
$9.98
Price range
$6.59
-
$15.86
Sold 0.2% shares (-37.9k shares)
Q2 2023
Avg closing price
$7.00
Price range
$4.56
-
$9.94
Increased shares by 1.3% (+315k shares)
Q1 2023
Avg closing price
$7.93
Price range
$6.42
-
$9.64
Increased shares by 14.9% (+3.23M shares)
Q4 2022
Avg closing price
$9.81
Price range
$7.16
-
$12.70
Sold 0.1% shares (-11k shares)
Q3 2022
Avg closing price
$10.13
Price range
$7.83
-
$13.60
Sold 1.7% shares (-376k shares)
Q2 2022
Avg closing price
$6.69
Price range
$5.04
-
$9.26
Sold 0.6% shares (-142k shares)
Q1 2022
Avg closing price
$10.63
Price range
$6.16
-
$18.03
Increased shares by 0.3% (+61.8k shares)
Q4 2021
Avg closing price
$18.82
Price range
$16.14
-
$21.86
Increased shares by 19.1% (+3.54M shares)
Q3 2021
Avg closing price
$28.34
Price range
$19.03
-
$41.33
New holding (+18.5M shares)
Q2 2021
Avg closing price
$29.60
Price range
$21.06
-
$37.42
News about Recursion Pharmaceuticals Inc - Ordinary Shares - Class A and Baillie Gifford
Baillie Gifford Reduces Stake in Recursion Pharmaceuticals Inc
Baillie Gifford Reduces Stake in Recursion Pharmaceuticals Inc